Top 10 Pharma Companies in USA 2016

Posted in Top Brand Lists, Total Reads: 337
Advertisements

Pharmaceutical companies are focusing a lot on research and development of drugs for treatment of cancer and rare disease drugs. Pharma companies have a hugely wide spread business across USA due to increasing need for healthcare among the American population. The top American pharma companies include Johnson & Johnson, Novartis, Roche, Pfizer and Gilead Sciences, along with brands like Merck & Co, GlaxoSmithKline, Sanofi, Amgen and AbbVie. Here is the list of the top 10 Pharmaceutical Companies in USA 2016.


10. AbbVie

AbbVie is a very young company. Established in 2013, the company is headquartered in Lake Bluff, Illinois, United States.


Image: company logo

The company has worldwide operations, and Richard A Gonzalez serves as the CEO and Chairman of the company. As of 2015, total 28,000 people work for the company, and the company is active in biopharmaceuticals and small molecule drugs.

Advertisements

AbbVie came into existence as a result of separation of Abbot Laboratories into two companies - Abbot Laboratories and AbbVie. Humira is the most selling product of the company accounting for sales of $14 billion.

In 2015 it AbbVie acquired Pharmacyclics, Inc which is a biopharmaceutical company. The company operates in only pharmaceutical products.

The company had a revenue of $ 22859 million in 2015. This was an increment of more than 22% over last year. Its total profits were $ 5144 million. The market capitalization of the company was at $ 97190 million. In 2015, AbbVie spent around $4.3 billion in research and development. AbbVie recently launched a disease education program - What's Your Sore Spot? This program is aimed to provide education to connect people with hidradenitis suppurativa (HS). This is a chronic skin disease.

Abbvie is also planning to acquire Stemcentrx. Stemcentrx is a cancel drug developer. The deal is around $ 10 billion.

PARAMETER(S)

Revenue: $ 22859 million

Net Profit/Loss: $ 5144 million

Market Capitalization: $ 97190 million